DAMAE Medical
PrivateLast Round
Series B
Nov 26, 2025
Total Funding Raised
$28.08M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DAMAE Medical operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series B round in November 2025.
DAMAE Medical is a diagnostic equipment company that develops non-invasive, in-vivo imaging technology for the cellular-resolution diagnosis of skin cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DAMAE Medical Comparables
Compare DAMAE Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Michelson Diagnostics Ltd. | 89% | |
| SquareMind | 75% | |
| Philophos | 75% |
For institutional investors. Book with your work email.
DAMAE Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 26, 2025 | ||||
| Series A | Feb 1, 2022 | ||||
| Grant | Sep 1, 2019 | ||||
| Seed | Apr 19, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DAMAE Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Idinvest Partners | Seed |
| BNP Paribas Développement | Series B, Series A |
| Eurazeo Investment Manager | Seed |
| Partech Partners | Series A |
| Creadev | Series B |
| European Union's Horizon 2020 research and innovation programme (Marie Skłodowska-Curie) | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 16, 3.3x the trailing average.
- Jul 20, 2026
Open roles increased to 12, representing 24% of headcount.
For institutional investors. Book with your work email.
DAMAE Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DAMAE Medical's valuation, stock price, and market status.
Is DAMAE Medical a public or private company?
DAMAE Medical is a private company.
What is the current stock price of DAMAE Medical?
DAMAE Medical is a private company, so its shares have no public market price. Caplight tracks DAMAE Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DAMAE Medical worth (valuation)?
Valuation information for DAMAE Medical is not publicly available.
Can I buy DAMAE Medical stock?
DAMAE Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DAMAE Medical's last funding round?
DAMAE Medical's most recent funding round was Series B on November 26, 2025.
Who are the main investors in DAMAE Medical?
Key investors in DAMAE Medical include BNP Paribas Développement, Creadev.
Will DAMAE Medical IPO soon?
No public IPO plans have been announced for DAMAE Medical.
How can I track DAMAE Medical secondary market activity?
Caplight tracks bids, offers, and trades in DAMAE Medical's shares on secondary markets.